As expected, romidepsin increased the mRNA expression levels of several genes such as those of the pluripotency factor SOX2 and the chemokines CCL2 and CCL20. However, expression of the transcription factor CEBPD, which is implicated in promoting cancer cell stemness (11) was inhibited (Fig. 1A). Here, CCL2 is linked to cancer.